ENHANCE SOLUBILITY AND PROLONG RELEASE OF PROCHLORPERAZINE MALEATE USING FLOATING NANOEMULSION IN SITU GEL

Authors

  • Yasser Q Almajidi Department of Pharmaceutics, Baghdad College of Medical Sciences, Baghdad, Iraq.
  • Ahmed A Albaderi Department of Pharmaceutics, Baghdad College of Medical Sciences, Baghdad, Iraq.
  • Hasan Fadhel Department of Pharmaceutical Chemistry, Baghdad College of Medical Sciences, Baghdad, Iraq.

DOI:

https://doi.org/10.22159/ajpcr.2019.v12i1.30486

Keywords:

Prochlorperazine maleate, Nanoemulsion, In situ gel, Sodium alginate, Hydroxypropyl methylcellulose 4M

Abstract

Objective: The objective of this study was to prepare floating gastric in situ gel of prochlorperazine maleate (PM) using nanoemulsion technology to improve drug solubility, bioavailability, reduce dosing frequency, and patient compliance.

Methods: Eight nanoemulsion formulas (F1–F8) of PM were prepared by ultrasonication method using oil, surfactants: cosurfactants (Smix) with different types, concentrations, and ratios, and deionized distilled water. The nanoemulsion formulas were characterized to select the optimum recipe from which six floating in situ gel formulas (floating nanoemulsion in situ [FNI] 1-FNI 6) were prepared using sodium alginate as gelling agent, hydroxypropyl methylcellulose (HPMCK) 4M as rate retarding polymer, calcium chloride as cross-linking agent, calcium carbonate as floating agent, and sodium citrate as buffering and neutralizing gastric acid. All FNI formulas were subjected for the evaluation to assess the formulations suitability concerning the dosage form and intended therapeutic purpose.

Results: Formulation variables such as the concentration of sodium alginate, HPMCK 4M, calcium carbonate, and calcium chloride affected the gelling properties, formulation viscosity, floating behavior, and in vitro drug release. Formulation FNI 6 showed acceptable floating lag time (55±2.3 s) and >12 h floating duration time, and observe prolong release of the drug in in-situ gelling preparation.

Conclusion: The prepared FNI formulas of PM could float in the gastric conditions and released the drug in a sustained manner. The present formulation was enhanced drug solubility with good retention properties and better patient compliance.

Downloads

Download data is not yet available.

Author Biography

Yasser Q Almajidi, Department of Pharmaceutics, Baghdad College of Medical Sciences, Baghdad, Iraq.

department of pharmaceutical chemistry

References

Jain CP, Joshi G, Kataria U, Patel K. Enhanced permeation of an antiemetic drug from buccoadhesive tablets by using bile salts as permeation enhancers: Formulation characterization, in vitro, and ex vivo studies. Sci Pharm 2016;84:379-92.

Moffat AC, Osselton MD, Widdop B. Clarke’s Analysis of Drugs and Poisons in Pharmaceuticals, Body Fluids, and Postmortem Material. 4th ed. Pharmaceutical Press; 2011.

Albadry AA, Ali WK, Al-saady FA. Formulation and Evaluation of Prochlorperazine Maleate Sustained Release Floating Tablet. Int J Pharm Pharm Sci 2017;9:89-98.

Rathod SH, Dhruti P, Mehta, Yadav JS. A Review on stomach specific floating in-situ gel. Indian J Pharm Sci 2014;6:19-30.

Sarada K, Firoz S, Padmini K. In-situ gelling system: A review. Int J Curr Pharm Res 2015;5:76-90.

Mahajan HS, Savale SK. Nanoemulsions: A versatile mode of drug delivery system. Indian J Nov Drug Deliv 2016;8:123-32.

Savardekar P, Bajaj A. Nanoemulsions-a review. Int J Res Pharm Chem 2016;6:312-22.

Sharma N, Bansal M, Visit S, Sharma PK, Kulkarni GT. Nanoemulsion: A new concept of the delivery system. Chron Young Sci 2010;1:2-6.

Almajidi YQ, Mahdi ZH, Marie NK. Preparation and in vitro evaluation of montelukast sodium oral nanoemulsion. Int J App Pharm 2018;10:49-53.

Beg S, Harikrishna D, Svitlana S, Feng Z, Jessica M, Galina G, et al. Ultrasonic emulsification of food-grade nanoemulsion formulation and evaluation of its bactericidal activity. Colloids and Surfaces B Biointerfaces 2013;101:414-23.

Sarwar BC, Sidharth SJ, Ch NP, Mohammad R, Suryakanta S, Sruti J, et al. Development of solid self-nano emulsifying granules (SSNEGs) of ondansetron hydrochloride with enhanced bioavailability potential. Colloids Surf B 2013;101:414-23.

Chand P, Gnanarajan PG, Kothiyal P. In situ gel: A review. Indian J Pharm Biol Res 2016;4:11-9.

Chaniyara S, Modi D, Patel R, Patel J, Desa R, Chaudhary S. Formulationand evaluation of floatable in situ gel for stomach-specific drug delivery of ofloxacin. Am J Adv Drug Deliv 2013;1:285-99.

Maheswaran A, Padmavathy J, Nandhini V, Saranana D, Angel P. Formulation and evaluation of floating oral in situ gel of diltiazem hydrochloride. Int J App Pharm 2017;9:50-3.

Jamee N, Kiran R, Kuchana V. Formulation and evaluation of floating oral in-situ gel of ranitidine hydrochloride. Indian J Palliati Care 2016;6:75-81.

Kajale AD, Chandewar AV. Design development and evaluation of gastro-retentive oral floating in-situ gel of metoprolol succinate. Indo Am J Pharm Sci 2016;6:5536-48.

Allen LV, Popovich NG, Ansel HC, editors. Disperse System. Philadelphia, PA: Lippincott Williams and Wilkins Publishing; 2011.

Ma TY, Hollander D, Krugliak P, Katz PK. PEG 400, a hydrophilic molecular probe for measuring intestinal permeability. Gastroenterology 1990;98:39-46.

Maraie NK, Almajidi YQ. Application of nanoemulsion technology for preparation and evaluation of intranasal mucoadhesivenano-in situ gel for ondansetron HCl. J Global Pharma Technol 2018;10:431-42.

United States Pharmacopeia. (USP 30) and the 25th edition of the National Formulary (NF25). USA: United States Pharmacopeial Convention Publishing; 2007.

Bobade NN, Pande SD. Formulation and evaluation of controlled release gastro-retentive in situ gel for diltiazem hydrochloride. Indian J Pharm Educ Res 2016;50:254-65.

Reddy RA, Ramesh B, Kishan V. Drug-excipient interaction during formulation development, in vitro and in vivo evaluation of gastroretentive drug delivery system for nizatidine. Int J Pharm Sci Nanotech 2013;6:2281-93.

Choi BY, Park HJ, Hwang SJ, Park JB. Preparation of alginate beads for the floating drug delivery system: Effects of CO2 gas-forming agents. Int J Pharm 2002;239:81-91.

Wamorkar V, Varma MM, Manjunath SY. Formulation and evaluation of stomach specific in situ gel of metoclopramide using natural, bio-degradable polymers. IJRPBS 2011;2:193-201.

Rajinikanth PS, Mishra B. Floating in situ gelling system for stomach site-specific delivery of clarithromycin to eradicate H. Pylori. J Control Release 2008;125:33-41.

Shastri DH, Dodiya HD, Shelat P, Priya AK. Formulation development and evaluation of a gastroretentive in situ oral gel of cefuroxime axetil. J Young Pharm 2016;8:324-29.

Thomas LM. Formulation and evaluation of floating in-situ gel of metronidazole. Int J Pharm Pharm Sci 2014;6:265-9.

Published

07-01-2019

How to Cite

Q Almajidi, Y., A. A Albaderi, and H. Fadhel. “ENHANCE SOLUBILITY AND PROLONG RELEASE OF PROCHLORPERAZINE MALEATE USING FLOATING NANOEMULSION IN SITU GEL”. Asian Journal of Pharmaceutical and Clinical Research, vol. 12, no. 1, Jan. 2019, pp. 537-541 Retracted Article, doi:10.22159/ajpcr.2019.v12i1.30486.

Issue

Section

Original Article(s)